Back to mobile site

Piper Jaffray Raises Price Target on Amsurg (AMSG) to $82 Following 2Q EPS Beat

August 5, 2015 9:47 AM EDT Send to a Friend
Piper Jaffray reiterated an Overweight rating on AmSurg (NASDAQ: AMSG), and raised the price target to $82.00 (from $72.00), following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login